Leandro Mena
Infectious Disease · Atlanta, GANPI 1497718027
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $87,162 of the $140,884 with a category attached, or 61.9%. 10 manufacturers reported payments, led by Gilead at 41.4% of the total. Reporting peaked in 2019 at $85,610 and has fallen 78.8% since, to $18,168 in 2025. Among infectious disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $819.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$58K
- Viiv Healthcare Company$52K
- Abbott$14K
- Merck$10K
- Roche Molecular Systems, Inc.$2K
- La Jolla Pharmaceutical Company$2K
- plus $2K from 4 others
Across 24 payments — averaging $24,673 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$378K
- Viiv Healthcare Company$186K
- Janssen Research & Development, LLC$13K
- Roche Molecular Systems, Inc.$11K
- BD$4K
- Lupin Inc.$275
- plus $14 from 1 others
What the payments were for
- Consulting fees$87,16262%
- Speaking & faculty fees$31,37822%
- Travel & lodging$18,71413%
- Food & beverage$3,5222%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 71 | $58,267 |
| Viiv Healthcare Company | 56 | $52,201 |
| Abbott | 15 | $14,277 |
| Merck | 15 | $9,745 |
| Roche Molecular Systems, Inc. | 1 | $2,400 |
| La Jolla Pharmaceutical Company | 2 | $1,769 |
| GSK | 9 | $1,109 |
| Orasure Technologies Inc. | 1 | $1,000 |
| Janssen Products, LP | 1 | $100 |
| Theratechnologies Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOVATO$17,351
- Descovy$8,675
- DELSTRIGO$6,950
- ALERE BINAXNOW INFLUENZA A & B CARD 2$6,871
- Truvada$3,300
- MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT$2,400
- InteliSwab$1,000
- Veklury$840
- TIVICAY$796
How this compares
$140,884 in reported general payments places this provider in the 95th percentile of 260 infectious disease providers in Georgia.
Other infectious disease in Atlanta
- Zandraetta Tims-CookAtlanta$848K
- Larry AndersonAtlanta$300K
- Quintin RobinsonAtlanta$270K
- James McMillenAtlanta$177K
- Colleen KraftAtlanta$103K
- Walter OrensteinAtlanta$78K
- Nadine RouphaelAtlanta$66K
- Kimberly WorkowskiAtlanta$53K
- Bernard BransonAtlanta$36K
- Michelle JonesAtlanta$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.